2018 MIPS Measure #116: Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis

Measure Type High Priority Measure? NQS Domain
Process No Efficiency and Cost Reduction
Data Submission Method(s)
Registry

Measure Description

The percentage of adults 18Ð64 years of age with a diagnosis of acute bronchitis who were not prescribed or dispensed an antibiotic prescription

Instructions

This measure is to be submitted at each occurrence of acute bronchitis during the performance period. This measure may be submitted by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. 

Measure Submission:

The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data.

Denominator

All patients aged 18 through 64 years of age with an outpatient, observation or emergency department (ED) visit with a diagnosis of acute bronchitis during the measurement period 

DENOMINATOR NOTE: To determine eligibility, look for any of the listed antibiotic drugs below in the 30 days prior to the visit with the acute bronchitis diagnosis. As long as there are no prescriptions for the listed antibiotics during this time period, the patient is eligible for denominator inclusion. Do not include observation or ED visits that result in an inpatient admission. An observation or ED visit results in an inpatient admission when the observation or ED date of service and the admission date for the inpatient stay are one calendar day apart or less.

*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for registrybased measures.

Denominator Criteria (Eligible Cases):

Patients18 through 64 years of age on date of encounter

AND

Diagnosis for acute bronchitis (ICD-10-CM): J20.3, J20.4, J20.5, J20.6, J20.7, J20.8, J20.9

AND

Patient encounter during the performance period (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99217, 99218, 99219, 99220, 99281, 99282, 99283, 99284, 99285, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99381, 99382, 99383, 99384, 99385, 99386, 99387, 99391, 99392, 99393, 99394, 99395, 99396, 99397, 99401, 99402, 99403,99404, 99411, 99412, 99420, 99429 ,99455, 99456, G0402, G0438, G0439, G0463*, T1015*

AND NOT

DENOMINATOR EXCLUSIONS:

Observation or ED visits that result in an inpatient admission

OR

Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, Lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/UTI, acne, HIV disease/asymptomatic HIV, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis: G9712

OR

Numerator

Patients who were not prescribed or dispensed antibiotics on or within 3 days of the initial date of service 

Numerator Instructions: For performance, the measure will be calculated as the number of patient encounters where antibiotics were neither prescribed nor dispensed on or within 3 days of the episode for acute bronchitis over the total number of encounters in the denominator (patients aged 18 through 64 years with an outpatient, observation or ED visit for acute bronchitis). A higher score indicates appropriate treatment of patients with acute bronchitis (e.g., the proportion for whom antibiotics were not prescribed or dispensed on or three days after the encounter). 

Antibiotic Medications

Description Prescription

Aminoglycosides

Amikacin

Tobramycin Gentamicin

Kanamycin

Streptomycin

Aminopenicillins

Amoxicillin

Ampicillin

Antipseudomonal penicillins

Piperacillin

Beta-lactamase inhibitors

Amoxicillin-clavulanate

Ampicillin- sulbactam 

Piperacillin-tazobactam

Ticarcillin-clavulanate

First-generation cephalosporins

Cefadroxil

Cephalexin

Cefazolin

Fourth-generation cephalosporins

Cefepime

Ketolides

Telithromycin

Lincomycin derivatives

Clindamycin Lincomycin

Macrolides

Azithromycin

Clarithromycin

Erythromycin stearate

Erythromycin

Erythromycin ethylsuccinate

Erythromycin lactobionate

Description Prescription

Miscellaneous antibiotics

Aztreonam

Chloramphenicol

Vancomycin

Dalfopristin-quinupristin

Linezolid

Daptomycin

Metronidazole

Erythromycin-sulfisoxazole

Natural penicillins

Penicillin G sodium benzathineprocaine

Penicillin G potassium Penicillin G procaine

Penicillin V potassium Penicillin G benzathine 

Penicillinase resistant penicillins

Dicloxacillin Oxacillin

Nafcillin

Quinolones

Ciprofloxacin Gemifloxacin Ofloxacin

Levofloxacin Moxifloxacin

Norfloxacin

Moxifloxacin

Rifamycin derivatives

Rifampin

Second generation cephalosporin

Cefaclor

Cefotetan Cefprozil

Cefoxitin

Cefuroxime

Sulfonamides

Sulfadiazine

Sulfamethoxazole-trimethoprim

Tetracyclines

Doxycycline Tetracycline

Minocycline

Third generation cephalosporins

Cefdinir Cefditoren Cefpodoxime

Cefixim

Cefotaxime

Ceftibuten

Ceftriaxone

Ceftazidime

Urinary anti-infectives

Fosfomycin

Nitrofurantoin macrocrystals

Trimethoprim

Nitrofuantoin

Nitrofurantoin macrocrystalsmonohydrate 

Numerator Options:

Performance Met:

Antibiotic neither prescribed nor dispensed (4124F)

OR

Performance Not Met:

Antibiotic prescribed or dispensed (4120F)

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.